Skip to main content

Table 1 Characteristics of the groups of patients for which genome-wide expression profiling was performed

From: Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity

  T2DM MetS Healthy controls p-value p-value p-value
  n = 6 n = 4 n = 3 T2DM vs C MetS vs C MetS vs T2DM
Age (years) 59.2 60.9 22.7 <0.0001 0.001 0.76
Sex (m/f) 6/0 3/1 3/0 1 1 0.40
Height (cm) 172.2 174.9 187.3 0.001 0.09 0.59
Weight (kg) 84.2 83.4 74.2 0.14 0.36 0.91
BMI (kg/m2) 28.5 27.1 21.1 0.02 0.03 0.56
Waist (cm) 102.1 97.6 79.2 0.02 0.07 0.57
Syst. BP (mm Hg) 143.5 133.7 114.7 0.02 0.06 0.32
Diast. BP (mm Hg) 85.3 84.2 70 0.03 0.06 0.87
FPG (mmol/l) 8.4 6.7 4.6 0.0002 0.0008 0.005
HbA1c (%) 6.6 5.9 na na na 0.10
Tot Chol (mmol/l) 4.8 5.2 4.4 0.51 0.24 0.48
HDL (mmol/l) 1.1 1.7 1.6 0.006 0.52 0.002
LDL (mmol/l) 3 3 2.4 0.34 0.25 0.97
TG (mmol/l) 1.9 1 0.9 0.02 0.66 0.01
  1. BMI; body mass index, Syst BP; systolic blood pressure, Diast BP; diastolic BP, FPG; fasting plasma glucose, HbA1c; hemoglobin A1c, Tot Chol; Total cholesterol, HDL; high density lipoproteins, LDL; low density lipoproteins, TG; triglycerides, na; not available, p-values were calculated by Student’s T-test, or Fisher’s exact for sex. p values <0.05 were considered significant (highlighted in bold)